Digoxin therapy in chronic heart failure

Cardiovascular Drugs and Therapy

Volumn 11, Issue SUPPL. 1, 1997, Pages 279-283

  Gheorghiade, Mihai ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chronic heart failure; Clinical efficacy; Digoxin; Hemodynamics; Neuroendocrine effects

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CAPTOPRIL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IBOPAMINE; MILRINONE; NORADRENALIN; VASODILATOR AGENT;

ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG TOXICITY; ENZYME INHIBITION; EXERCISE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; HEMODYNAMICS; HOSPITALIZATION; HUMAN; META ANALYSIS; MORTALITY; NORADRENALIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REST; SURVIVAL; SYSTOLE;

CARDIAC OUTPUT, LOW; CARDIOTONIC AGENTS; CHRONIC DISEASE; DIGOXIN; HEMODYNAMIC PROCESSES; HUMANS; RANDOMIZED CONTROLLED TRIALS; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME;

EID: 0030904259     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007743930938     Document Type: Article

References (31)

1. Yusuf CS, Wittes J, Bailey K, Furberg C. Digitalis - a new controversy regarding an old drug. Circulation 1986; 73:14-18.
2. Beller GA, Smith TW, Abelmann WH, Haber E, Hood WB. Digitalis intoxication: A prospective clinical study with serum level correlations. N Engl J Med 1971;284:990-999.
3. Mahdyoon H, Battilana G, Rosman H, Goldstein S, Gheorghiade M. The evolving pattern of digoxin intoxication: Observations at a large urban hospital from 1980 to 1988. Am Heart J 1990;120:1189-1194.
4. Smith TW. Digitalis: Mechanisms of action and clinical use. N Engl J Med 1988;318:358-365.
5. Ribner HS, Plucinski DA, Hsie AM, Bresnahan D, Molteni A, Askenazi J, Lesch M. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: A hemodynamic-hormonal study. Am J Cardiol 1985;56:896-904.
6. Gheorghiade M, St. Clair J, Beller GA. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators. J Am Coll Cardiol 1987;9:849-857.
7. Gheorghiade M, Hall V, Lakier J, Goldstein S. Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure. J Am Coll Cardiol 1989;13:134-142.
8. Arnold SB, Byrd RC, Meister W, et al. Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med 1980;303:1443-1448.
9. Schmidt TA, Allen PD, Colucci WS, Marsh JD, Kjeldsen K. No adaptation to digitalization as evaluated by digitalis receptor (Na, K-ATPase) quantification in explanted hearts from donors without heart disease and from digitalized recipients with end-stage heart failure. Am J Cardiol 1992; 70:110-114.
10. Gheorghiade M, Hall VB, Jacobsen G, Alam M, Rosman H, Goldstein S. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diretics and angiotensin-converting enzyme inhibitors. Circulation 1995; 92:1801-1807.
11. Eichorn EJ, Alvarez LG, Willard JE, Grayburn PA. Digitalis improves myocardial relaxation in patients with heart failure (abstr). J Am Coll Cardiol 1992;19:254.
12. Feldman MD, Copelas L, Gwthmey JK, et al. Deficient production of cyclic AMP: Pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 1987;75:331-339.
13. Benedict CR, Johnstone DE, Weiner DH, et al. for the SOLVD Investigators. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the registry of studies of left ventricular dysfunction. J Am Coll Cardiol 1994;23:1410-20.
14. Ellenbogen KA, Mohanty PK, Szentpetery S, Thames MD. Arterial baroreflex abnormalities in heart failure: Reversal after orthotopic cardiac transplantation. Circulation 1989; 79:51-58.
15. Svedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the CONSENSUS Trial Study Group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990;82:1730-1736.
16. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients: Direct evidence from sympathetic neural recordings. Circulation 1989;80:65-77.
17. Wang W, Chen JW, Zucker I. Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation 1990; 81:1959-1966.
18. Van Veldhuisen DJ, Man in't Veld A, Dunselman PHJM, et al. on behalf of the DIMT Study Group. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: Results of the Dutch Ibopamine Multicenter Trial (DIMT). J Am Coll Cardiol 1993;22:1564-1573.
19. Brouwer J, van Veldhuisen DJ, Man in't Veld AJ, Dunselman PHJM, Boomsma F, Haaksma J, Lie KI, for the DIMT Study Group. Heart rate variability in patients with mild to moderate heart failure: Effects of neurohormonal modulation by digoxin and ibopamine. J Am Coll Cardiol 1995;26:983-990.
20. Krum H, Bigger JT, Goldsmith RL, Packer M. Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol 1995;25:289-294.
21. Newton GE, Tong JH, Schofield AM, Baines AD, Floras JA, Parker JD. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure. J Am Coll Cardiol 1996;28:155-161.
22. The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988; 259:539-544.
23. DiBianco R, Shabetai R, Kostuk W, et al. for the Milrinone Multicenter Trial Group. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989;320:677-683.
24. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK, on behalf of the PROVED Investigative Group. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED Trial. J Am Coll Cardiol 1993;22:955-962.
25. Packer M, Gheorghiade M, Young JB, et al. for the RADIANCE Study. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med 1993;329:1-7.
26. Gheorghiade M, Young JB, Uretsky B, Havstad S, Tilley B on behalf of the PROVED and RADIANCE Investigators. Predicting clinical deterioration after digoxin withdrawal in heart failure (abstr). Circulation 1993;88:1-604.
27. Young JB, Gheorghiade M, Packer M, Uretsky B, Hull H on behalf of the PROVED and RADIANCE investigators. Are low serum levels of digoxin effective in chronic heart failure? Evidence challenging the accepted guidelines for a therapeutic serum level of the drug (abstr). J Am Coll Cardiol 1993;21:378a.
28. Young JB, Gheorghiade M, Packer M, Uretsky B, on behalf of the PROVED and RADIANCE Trials. Superiority of "triple" drug therapy in congestive heart failure: Insights from the PROVED and RADIANCE Investigators. Presented at the Working Group on Heart Failure of the European Society of Cardiology, Heart Failure '95, Amsterdam, The Netherlands, April 1-4,1995.
29. Gheorghiade M, Young JB, Uretsky BF, Packer M, on behalf of the PROVED and RADIANCE Investigators. The effects of digoxin withdrawal in patients with stable heart failure due to coronary artery disease compared to primary cardiomyopathy; Insights from the PROVED and RADIANCE Studies (abstr). Circulation 1995;I142.
30. Kraus E, Rudolph C, Rudolph W. Wirksamkeit von Digitalis bei Patienten mit chronischer Herzinsuffizienz und Sinusrhythmus. Herz 1993;18:95-117.
31. The Digitalis Investigators Group. The effect of digoxin on mortality and morbidity in patients with heart failure. New Engl J Med 1997;336:525-533.